NIPPON YUSEN KA/S (OTCMKTS:NPNYY) and ReNeuron Group (OTCMKTS:RNUGF) are both transportation companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, institutional ownership, risk, profitability, analyst recommendations and dividends.
Valuation and Earnings
This table compares NIPPON YUSEN KA/S and ReNeuron Group’s gross revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|NIPPON YUSEN KA/S||$16.48 billion||0.18||-$400.95 million||N/A||N/A|
|ReNeuron Group||$60,000.00||1,086.65||-$23.36 million||N/A||N/A|
This is a summary of current ratings and target prices for NIPPON YUSEN KA/S and ReNeuron Group, as provided by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|NIPPON YUSEN KA/S||0||0||0||0||N/A|
ReNeuron Group has a consensus target price of $6.00, suggesting a potential upside of 191.26%. Given ReNeuron Group’s higher possible upside, analysts clearly believe ReNeuron Group is more favorable than NIPPON YUSEN KA/S.
This table compares NIPPON YUSEN KA/S and ReNeuron Group’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|NIPPON YUSEN KA/S||N/A||N/A||N/A|
NIPPON YUSEN KA/S pays an annual dividend of $0.03 per share and has a dividend yield of 0.9%. ReNeuron Group does not pay a dividend.
Risk & Volatility
NIPPON YUSEN KA/S has a beta of 1.36, meaning that its share price is 36% more volatile than the S&P 500. Comparatively, ReNeuron Group has a beta of -56.58, meaning that its share price is 5,758% less volatile than the S&P 500.
Insider & Institutional Ownership
0.0% of NIPPON YUSEN KA/S shares are owned by institutional investors. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
NIPPON YUSEN KA/S Company Profile
Nippon Yusen Kabushiki Kaisha provides ocean, land, and air transportation services worldwide. It operates through Global Logistics, Bulk Shipping, and Others segments. The company offers various logistics services, including liner trading services, such as container shipping, and terminal and stevedoring services for containerships, car carriers, and cruise ships; and air cargo transportation services. It is also involved in the bulk shipping business comprising car transportation, car terminals development, and inland transportation networks construction; dry bulk transportation of freight that include iron ore, coal, and wood-chips; liquid transportation activities, which comprise crude oil, petroleum products, chemicals, and liquefied natural gas for petroleum, petrochemical, and energy companies; and upstream areas of the supply chain for oil and natural gas. In addition, the company operates Asuka II, a luxury cruise ship; and manages commercial and residential buildings, as well as researches and develops transport systems. Nippon Yusen Kabushiki Kaisha was founded in 1885 and is headquartered in Tokyo, Japan.
ReNeuron Group Company Profile
ReNeuron Group plc develops and sells cell-based therapies in the United Kingdom. The company's lead therapeutic candidate is CTX stem cell therapy, which has been completed Phase II clinical trial for the treatment of patients living with chronic disability following stroke, as well as that has been completed Phase I clinical trial to treat limb ischaemia. It is also involved in developing human retinal progenitor cell candidate, which is in Phase I/II clinical trial for the treatment of retinitis pigmentosa, a blindness-causing disease of the retina, as well as that is in Phase I clinical trial to treat cone-rod dystrophy, an inherited eye disorder; and CTX-derived exosomes, which are nanoparticles released by cells containing various active proteins and microRNAs. ReNeuron Group plc was founded in 1997 and is headquartered in Pencoed, the United Kingdom.
Receive News & Ratings for NIPPON YUSEN KA/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NIPPON YUSEN KA/S and related companies with MarketBeat.com's FREE daily email newsletter.